GPCR - Structure Therapeutics Inc.

QQQ $ 451.63 $ -0.22 (-0.05 %)

DIA $ 399.76 $ 0.74 (0.19 %)

SPY $ 529.24 $ 0.76 (0.14 %)

TLT $ 91.40 $ -0.62 (-0.67 %)

GLD $ 223.63 $ 3.63 (1.65 %)

Previous Close

$ 36.15

Open

$ 35.74

Bid

$ 36.07 x 200

Ask

$ 0.00 x 0

Day's Range

$ 35.31 - $ 36.74

52 Week Range

$ 21.79 - $ 75.02

Volume

434,235

Average Volume

Market Cap

5.05B

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-08-2024	12-31-2023	10-K
3	11-17-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-30-2023	12-31-2022	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JMP Securities Reiterates Market Outperfor...
05/10/2024 16:50:39

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

Structure Therapeutics Q1 EPS $(0.19) Beat...
05/09/2024 22:41:34

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate o...

Cantor Fitzgerald Reiterates Overweight on...
05/03/2024 15:22:18

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:53:16

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

Cantor Fitzgerald Initiates Coverage On St...
04/09/2024 11:03:21

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Overweight ratin...

JMP Securities Reiterates Market Outperfor...
03/08/2024 18:02:55

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

Structure Therapeutics Reports Year-End Ca...
03/08/2024 13:41:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
12/19/2023 13:07:32

nasdaq-gains-100-points-biomerica-shares-spike-higher

Nasdaq Gains 100 Points; Biomerica Shares ...
12/18/2023 19:21:38

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The D...

why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Lantheus Holdings Shares Are Trading L...
12/18/2023 18:05:04

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
12/18/2023 17:32:13

Crude Oil Rises 3%; US Housing Market Inde...
12/18/2023 17:17:23

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded ...

why-is-novo-nordisks-potential-obesity-drug-rival-structure-therapeutics-stock-tanking-today

Why Is Novo Nordisk's Potential Obesity Dr...
12/18/2023 16:20:41

Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development progr...

dow-gains-over-50-points-nippon-steel-to-acquire-u-s-steel

Dow Gains Over 50 Points; Nippon Steel To ...
12/18/2023 14:51:14

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market open...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
12/18/2023 13:08:00

Structure Therapeutics Provides Comprehens...
12/18/2023 12:35:58

Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecu...

JMP Securities Reiterates Market Outperfor...
11/20/2023 14:16:58

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

What 6 Analyst Ratings Have To Say About S...
11/15/2023 19:00:48

JMP Securities Maintains Market Outperform...
11/15/2023 17:50:23

JMP Securities analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and raises ...

Structure Therapeutics EPS $(0.21) Up From...
11/14/2023 22:12:32